Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bilirubin Removal With Therapeutic Plasma Exchange Or Molecular Adsorbent Recirculating System (MARS®) As Treatment For Cholemic Nephropathy In Patients With Cirrhosis and ACLF: A case series.
Jiménez-Esquivel N, Piñeiro G, Carpio A, Ortiz O, Lozano M, Rodríguez-Carunchio L, Salgado MDC, Toapanta D, Cid J, Bassegoda O, Cuadrado-Payán E, Sanz M, Charry P, Poch E, Fernández J, Reverter E. Jiménez-Esquivel N, et al. Among authors: sanz m. Blood Purif. 2025 Jan 17:1-12. doi: 10.1159/000543619. Online ahead of print. Blood Purif. 2025. PMID: 39827849
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension.
Adams D, Wixner J, Polydefkis M, Berk JL, Conceição IM, Dispenzieri A, Peltier A, Ueda M, Bender S, Capocelli K, Jay PY, Yureneva E, Obici L; patisiran Global OLE study group. Adams D, et al. JAMA Neurol. 2025 Jan 13. doi: 10.1001/jamaneurol.2024.4631. Online ahead of print. JAMA Neurol. 2025. PMID: 39804640
Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks.
Suárez-García I, Alejos B, Moreno C, Martín Torres J, Masiá M, García-Fraile LJ, Riera M, Dalmau D, Rodríguez-Rosado R, Muga R, Moreno S, Jarrín I; CoRIS cohort. Suárez-García I, et al. J Antimicrob Chemother. 2024 Dec 23:dkae456. doi: 10.1093/jac/dkae456. Online ahead of print. J Antimicrob Chemother. 2024. PMID: 39710424
Incidence, Risk Factors, and Outcomes of BK Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplantation From HLA-Matched and Haploidentical Donors With Post-Transplant Cyclophosphamide.
Chorão P, Villalba M, Balaguer-Roselló A, Montoro J, Granados P, Gilabert C, Panadero F, Pardal AA, González EM, de Cossio S, Benavente R, Gómez MD, Gómez I, Solves P, Santiago M, Asensi P, Lloret P, Eiris J, Martínez D, Louro A, Rebollar P, Perla A, Salavert M, Rubia J, Sanz MÁ, Sanz J. Chorão P, et al. Among authors: sanz ma. Transplant Cell Ther. 2024 Dec 17:S2666-6367(24)00809-1. doi: 10.1016/j.jtct.2024.12.006. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39701290
Peri-implant bone regeneration in pigs.
Shanbhag S, Sanz-Esporrin J, Kampleitner C, Lie SA, Gruber R, Mustafa K, Sanz M. Shanbhag S, et al. Among authors: sanz m. Int J Implant Dent. 2024 Nov 15;10(1):55. doi: 10.1186/s40729-024-00572-9. Int J Implant Dent. 2024. PMID: 39546101 Free PMC article. Review.
Early death and intracranial hemorrhage prediction in acute promyelocytic leukemia: validation of a risk score in a chemotherapy plus ATRA cohort from an international consortium.
Silva WF, Kim HT, Undurraga MS, Navarro-Cabrera JR, Salinas V, Muxi P, Melo RAM, Gloria ABF, Pagnano KBB, Nunes EC, Bittencourt RI, Rojas N, Truyenque SMQ, Ayala-Lugo AI, Oliver AC, Figueiredo-Pontes LL, Traina F, Moreira F, Fagundes EM, Duarte BKL, Mora-Alferez AP, Ortiz P, Untama JL, Tallman MS, Ribeiro RC, Ganser A, Dillon RJ, Valk PJM, Sanz MA, Löwenberg B, Berliner N, Rego EM. Silva WF, et al. Among authors: sanz ma. Haematologica. 2024 Oct 31. doi: 10.3324/haematol.2024.286338. Online ahead of print. Haematologica. 2024. PMID: 39479861 Free article.
2,307 results